Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS 2023-05-17 07:00
Boan Biotech's BA1202 Approved for Clinical Trial 2023-05-16 22:02
DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president 2023-05-16 21:00
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan 2023-05-16 19:00
Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts 2023-05-16 18:00
LYNK's LNK01001 Achieved Exciting Phase II Results in Rheumatoid Arthritis 2023-05-16 08:00
Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech's Dulaglutide Injection BA5101 in China 2023-05-15 21:58
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma 2023-05-15 18:30
BOTTICELLI, THE INQUIETUDE AND THE BEAUTY - Menarini presents in Florence its latest art monograph, dedicated to the symbol of the Italian Renaissance 2023-05-15 16:20
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis 2023-05-15 12:30
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma 2023-05-15 08:00
Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore 2023-05-12 21:01
CRM Trial Connect 2023: Minister of Health Malaysia, Dr. Zaliha Mustafa visits Taimei Technology's booth 2023-05-12 19:36
Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology 2023-05-12 17:40
Nefecon Included in the Reimbursement Drug List of "Beijing Puhui Health Insurance Program" as a First-in-Disease Therapy for IgA Nephropathy 2023-05-12 07:40
Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology 2023-05-11 20:55
PFIZER CALLS FOR MORE AWARENESS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) - A RARE, LIFE-THREATENING DISEASE 2023-05-11 16:10
Nippon Express Italia Obtains IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport 2023-05-11 14:00
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector 2023-05-11 09:00
Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint 2023-05-11 08:45
1 95 96 97 98 99 290